Login

Consolidated balance sheets

In USD, except per-share amounts
Q1 FY2027
As of Sep 30, 2026
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Cash and cash equivalents
Total current assets
TOTAL ASSETS
Accrued expenses
Other payable
Amount due to (from) a director
Total current liabilities
Total Liabilities
Common stock, $0.001 par value; 10,330,730 shares issued and outstanding
Additional paid-in-capital
Accumulated deficit
Total Stockholders’ Equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support